This site is intended for healthcare professionals
  • Home
  • /
  • Journals
  • /
  • Melanomas of skin
  • /
  • Encorafenib in combination with binimetinib for un...
Journal

Encorafenib in combination with binimetinib for unresectable or metastatic melanoma with BRAF mutations.

Read time: 1 mins
Published:1st Mar 2019
Author: Trojaniello C, Festino L, Vanella V, Ascierto PA.
Availability: Pay for access, or by subscription
Ref.:Expert Rev Clin Pharmacol. 2019;12(3):259-266.
DOI:10.1080/17512433.2019.1570847
Register for free access to this exclusive healthcare learning resource


Why sign up with Medthority?

Develop your knowledge with our disease and condition focused Learning Zones

Access content from credible sources, including expert-led commentary, videos, podcasts, and webinars as well as clinical trials, treatment information and guidelines 

Personalised dashboard providing updates and recommendations for content within your areas of interest